Skip to main content

editorial

. 1990 Nov 24;301(6762):1172–1173. doi: 10.1136/bmj.301.6762.1172

First line treatment in hypertension.

PMCID: PMC1664324 PMID: 1979755

1172

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
MacMahon S. W., Cutler J. A., Furberg C. D., Payne G. H. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):99–118. doi: 10.1016/0033-0620(86)90038-1. [DOI] [PubMed] [Google Scholar]
Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES